Twist Bioscience Corporation
TWST
$42.34
$2.385.96%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 26.54% | 25.06% | -49.09% | 23.10% | -2.83% |
| Total Depreciation and Amortization | -21.92% | -46.63% | -2.23% | 18.16% | 54.40% |
| Total Amortization of Deferred Charges | -- | 188.89% | -- | -- | -- |
| Total Other Non-Cash Items | 5.64% | -16.74% | 332.78% | 47.72% | 291.45% |
| Change in Net Operating Assets | -1,638.53% | -358.50% | 4.55% | 287.27% | 104.58% |
| Cash from Operations | 6.73% | 26.00% | 72.76% | 56.14% | 57.51% |
| Capital Expenditure | -50.60% | 16.34% | 78.60% | 93.34% | 87.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -87.09% | 391.10% | -98.90% | -109.23% | 16.86% |
| Cash from Investing | -136.88% | 42.81% | -103.81% | -112.73% | 159.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 210.20% | 131.23% | 725.78% | 20.70% | 57.45% |
| Repurchase of Common Stock | 99.75% | 99.29% | 99.31% | -21.71% | -142.64% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,318.19% | 720.59% | 539.94% | 19.87% | -272.91% |
| Foreign Exchange rate Adjustments | -145.69% | 252.08% | 100.63% | -189.04% | -56.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 74.84% | 42.79% | 26.98% | -1,396.73% | 67.03% |
